Inadequate response to ustekinumab in atopic dermatitis - a report of two patients

J Eur Acad Dermatol Venereol. 2016 Mar;30(3):522-3. doi: 10.1111/jdv.12918. Epub 2014 Dec 16.

Authors

L P Samorano¹, J M Hanifin², E L Simpson², Y A Leshem²

Affiliations

¹ Department of Dermatology, Hospital das Clínicas, University of São Paulo Medical School, Sao Paulo, Brazil.
² Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.

PMID: 25510643
DOI: 10.1111/jdv.12918

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Topical
Dermatitis, Atopic / chemically induced*
Dermatitis, Atopic / diagnosis
Dermatitis, Atopic / immunology
Dermatologic Agents / administration & dosage
Dermatologic Agents / adverse effects
Female
Humans
Immunity, Cellular / drug effects*
Interleukin-17 / immunology
Interleukin-17 / metabolism
Male
Middle Aged
Skin / drug effects
Skin / pathology*
Th1 Cells / immunology
Th17 Cells / immunology
Ustekinumab / administration & dosage
Ustekinumab / adverse effects*
Young Adult

Substances

Dermatologic Agents
Interleukin-17
Ustekinumab